MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Charts
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
PRGO

PRGO

Perrigo Company plc

$14.47
-0.29
 (-1.96%)
Exchange:  NYSE
Market Cap:  2.002B
Shares Outstanding:  69.756M
Delayed data
Calculate PRGO Intrinsic Value
5-year outlook →
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Healthcare
Industry:  Drug Manufacturers – Specialty & Generic
   
CEO:  Albert A. Manzone
Full Time Employees:  8100
Address: 
The Sharp Building
Dublin
DU
D02 TY74
IE
Website:  https://www.perrigo.com
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women’s health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Click to read more…

Revenue Segmentation

MARKETSnap
MARKETSnap

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Login — it's free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2026/05/06 — Q1 quarter 2026

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue4,655,6004,373,4004,253,100
Gross Profit1,680,4001,542,7001,494,500
EBITDA525,000433,000-797,900
Operating Income151,900112,900343,300
Net Income-12,700-171,800-1,425,400

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets10,809,1009,647,7008,535,200
Total Liabilities6,041,2005,328,3005,599,700
Total Stockholders Equity4,767,9004,319,4002,935,500
Total Debt4,073,4003,618,10036,600
Cash and Cash Equivalents751,300558,800531,600

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow405,500362,900238,500
Capital Expenditure-101,700-118,300-93,400
Free Cash Flow303,800244,600145,100
Net Income-12,700-171,800-1,425,400
Net Change in Cash150,600-192,500-561,100

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2030Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Low)4,055,947.760Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (High)4,150,645.993Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Avg)4,107,000Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Low)220,784.895Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (High)225,939.779Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Avg)223,563.916Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Low)395,159.892Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (High)407,198.312Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Avg)401,650.002Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Low)967,217.610Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (High)989,800.199Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Avg)979,391.985Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Avg)2.900Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (High)2.940Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Low)2.850Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated Revenue)2Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated EPS)1Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
4.374B  ?P/S
 (TTM)
: 
0.48
?Net Income
 (TTM)
: 
-171800000  ?P/E
 (TTM)
: 
-1.14
?Enterprise Value
 (TTM)
: 
4.867B  ?EV/FCF
 (TTM)
: 
27.81
?Dividend Yield
 (TTM)
: 
8.14%  ?Payout Ratio
 (TTM)
: 
-11.52%
?ROE
 (TTM)
: 
-55.97%  ?ROIC
 (TTM)
: 
3.27%
?Net Debt
 (TTM)
: 
3.241B  ?Debt/Equity
 (TTM)
: 
1.31
?P/B
 (TTM)
: 
0.79  ?Current Ratio
 (TTM)
: 
2.32

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Research Access for high/low estimates and the interactive table.

Forward P/E 1YResearch AccessResearch AccessResearch AccessResearch Access
5.08Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

Based on current fundamentals and analyst forecasts, MARKETSnap estimates PRGO intrinsic value between $25.30 – $26.19 per share. This depends on revenue growth, margins, and discount rate.

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.

[intrinsic_calculator]

Common questions about PRGO valuation

Is Perrigo Company plc (PRGO) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for Perrigo Company plc (PRGO) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is PRGO a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether PRGO trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is PRGO’s P/E ratio?

You can see PRGO’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for PRGO?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is PRGO a good long-term investment?

Whether PRGO fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

PRGO

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

-1.96
MARKETSnap

Trading Metrics:

Open: 14.63   Previous Close: 14.76
Day Low: 14.34   Day High: 14.65
Year Low: 9.23   Year High: 23.98
Price Avg 50: 11.3   Price Avg 200: 12.18
Volume: 325490   Average Volume: 3.085M

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

PRGO or NEOG: Which Is the Better Value Stock Right Now?
26-08-2026 12:41
PRGO or NEOG: Which Is the Better Value Stock Right Now?
Perrigo Company plc (PRGO) Q2 2026 Earnings Call Transcript
05-08-2026 14:00
Perrigo Company plc (PRGO) Q2 2026 Earnings Call Transcript
Perrigo Reports Second Quarter 2026 Financial Results From Continuing Operations
05-08-2026 06:30
Perrigo Reports Second Quarter 2026 Financial Results From Continuing Operations
Perrigo CEO Ousted Over Personal Conduct
08-06-2026 17:11
Perrigo CEO Ousted Over Personal Conduct
Perrigo Announces Leadership Transition
08-06-2026 16:18
Perrigo Announces Leadership Transition
Perrigo Q1 Earnings Surpass Estimates, Sales Miss, Both Fall Y/Y
07-05-2026 14:01
Perrigo Q1 Earnings Surpass Estimates, Sales Miss, Both Fall Y/Y

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
      • Large Caps
      • Absolute
      • Total Market PE
      • Large Caps
      • Absolute
      • Industry
      • Sector
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Philosophy
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlist & Portfolio Watchlist & Portfolio
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read